81 related articles for article (PubMed ID: 31239153)
21. Glucose deprivation promotes pseudo-hypoxia and de-differentiation in lung adenocarcinoma.
Saggese P; Pandey A; Fung E; Hall A; Yanagawa J; Rodriguez EF; Grogan TR; Giurato G; Nassa G; Salvati A; Weisz A; Dubinett SM; Scafoglio C
bioRxiv; 2023 Feb; ():. PubMed ID: 36778362
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-induced P4HA1 overexpression promotes post-ischemic angiogenesis by enhancing endothelial glycolysis through downregulating FBP1.
Xu Y; Xia D; Huang K; Liang M
J Transl Med; 2024 Jan; 22(1):74. PubMed ID: 38238754
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of collagen prolyl hydroxylases in ovarian cancer is associated with cancer growth and metastasis.
Song M; Schnettler E; Venkatachalam A; Wang Y; Feldman L; Argenta P; Rodriguez-Rodriguez L; Ramakrishnan S
Am J Cancer Res; 2023; 13(12):6051-6062. PubMed ID: 38187063
[TBL] [Abstract][Full Text] [Related]
24. P4HA1 expression and function in esophageal squamous cell carcinoma.
Gou W; Song B; Yang Y
Medicine (Baltimore); 2023 Dec; 102(51):e36800. PubMed ID: 38134053
[TBL] [Abstract][Full Text] [Related]
25. Exploring the glycolytic cross-talk genes between inflammatory bowel disease and colorectal cancer.
Ye C; Huang Y; Gao Y; Zhu S; Yuan J
Funct Integr Genomics; 2023 Jul; 23(3):230. PubMed ID: 37428395
[TBL] [Abstract][Full Text] [Related]
26. Re-Shaping the Pancreatic Cancer Tumor Microenvironment: A New Role for the Metastasis Suppressor NDRG1.
Chang J; Lo ZHY; Alenizi S; Kovacevic Z
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345116
[TBL] [Abstract][Full Text] [Related]
27. Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway.
Araki O; Tsuda M; Omatsu M; Namikawa M; Sono M; Fukunaga Y; Masuda T; Yoshikawa T; Nagao M; Ogawa S; Masuo K; Goto N; Muta Y; Hiramatsu Y; Maruno T; Nakanishi Y; Koyasu S; Masui T; Hatano E; Saur D; Fukuda A; Seno H
Oncogene; 2023 Jun; 42(26):2139-2152. PubMed ID: 37198398
[TBL] [Abstract][Full Text] [Related]
28. BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis.
Agarwal S; Afaq F; Bajpai P; Behring M; Kim HG; Varambally A; Chandrashekar DS; Peter S; Diffalha SA; Khushman M; Seeber A; Varambally S; Manne U
Mol Cancer Res; 2023 Jul; 21(7):698-712. PubMed ID: 37067340
[TBL] [Abstract][Full Text] [Related]
29. The role of metabolic reprogramming in pancreatic cancer chemoresistance.
Liu C; Li C; Liu Y
Front Pharmacol; 2022; 13():1108776. PubMed ID: 36699061
[TBL] [Abstract][Full Text] [Related]
30. Molecular Classification of Genes Associated with Hypoxic Lipid Metabolism in Pancreatic Cancer.
Li Y; Liang X; Che G; Chen Y; Luo L; Liu K; Xie R; Zeng L
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291742
[TBL] [Abstract][Full Text] [Related]
31. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.
Gao H; Xing F
BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131
[TBL] [Abstract][Full Text] [Related]
32. The Role of P4HA1 in Multiple Cancer Types and its Potential as a Target in Renal Cell Carcinoma.
Li Y; Ge YZ; Qian Y; Chen K; Zhao F; Qin Z; Zhou L; Xu L; Xu Z; Dou Q; Jia R
Front Genet; 2022; 13():848456. PubMed ID: 35812752
[No Abstract] [Full Text] [Related]
33. Context Matters: Response Heterogeneity to Collagen-Targeting Approaches in Desmoplastic Cancers.
Fuller AM; Eisinger-Mathason TSK
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804902
[TBL] [Abstract][Full Text] [Related]
34. The Role of Feedback Loops in Targeted Therapy for Pancreatic Cancer.
Gu W; Shen H; Xie L; Zhang X; Yang J
Front Oncol; 2022; 12():800140. PubMed ID: 35651786
[TBL] [Abstract][Full Text] [Related]
35. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review.
Koltai T; Reshkin SJ; Carvalho TMA; Di Molfetta D; Greco MR; Alfarouk KO; Cardone RA
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626089
[TBL] [Abstract][Full Text] [Related]
36. VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells.
Ma X; Tan Z; Zhang Q; Ma K; Xiao J; Wang X; Wang Y; Zhong M; Wang Y; Li J; Zeng X; Guan W; Wang S; Gong K; Wei GH; Wang Z
Cell Biosci; 2022 May; 12(1):52. PubMed ID: 35505422
[TBL] [Abstract][Full Text] [Related]
37. P4HA1 Regulates CD31
Han X; Wang Q; Fang S; Wang J; Liu F; Zhang J; Jin G
Front Oncol; 2022; 12():836511. PubMed ID: 35494018
[TBL] [Abstract][Full Text] [Related]
38. HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer.
Hamada S; Matsumoto R; Masamune A
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053572
[TBL] [Abstract][Full Text] [Related]
39. P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer.
Zhao Q; Liu J
Front Cell Dev Biol; 2021; 9():754580. PubMed ID: 34966739
[No Abstract] [Full Text] [Related]
40. Molecular aspects of pancreatic cancer: focus on reprogrammed metabolism in a nutrient-deficient environment and potential therapeutic targets.
Słotwiński R; Lech G; Słotwińska SM
Cent Eur J Immunol; 2021; 46(2):258-263. PubMed ID: 34764796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
